Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized, Placebo-controlled, Phase III Study for Reducing Dependency and Cardiovascular Events With Oral Colchicine 0.5mg Once Daily Compared With Placebo in Participants With Spontaneous Intracerebral Hemorrhage and Established, or Risk Factors for, Atherosclerosis

NCT06587737 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT06587737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06587737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized, Placebo-controlled, Phase III Study for Reducing Dependency and Cardiovascular Events With Oral Colchicine 0.5mg Once Daily Compared With Placebo in Participants With Spontaneous Intracerebral Hemorrhage and Established, or Risk Factors for, Atherosclerosis
Lead sponsor
Population Health Research Institute
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
October 30, 2028
Enrollment
1,125 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colchicine, dependence, ich - intracerebral hemorrhage, stroke